| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Wu,Xin-Hong | Chairman | 3.65% | |
| Cai,Jie-Rong | Vice Chairman | 0.17% | |
| Zhang,Chun-Ming | Director | 23.90% | SAN FU GLOBAL CO., LTD. |
| Su,Tian-Bao | Director | 0.27% | |
| Zhang,Yi-Zong | Director | 0.28% | |
| Liang,Guo-Yuan | Director | 0.00% | |
| Yang,Hong-Zhi | Independent Director | 0.01% | |
| Xie,Yong-Fen | Independent Director | 0.00% | |
| Wu,Dong-Ming | Independent Director | 0.00% |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating income | 1,163,547 | 5,324,424 | 4,990,961 |
| Operating cost | 903,386 | 4,313,355 | 3,968,584 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 260,161 | 1,011,069 | 1,022,377 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 260,161 | 1,011,069 | 1,022,377 |
| Operating expenses | 120,232 | 502,913 | 464,460 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | 139,929 | 508,156 | 557,917 |
| Non-operating income and expenses | 10,013 | 59,194 | 23,393 |
| Net profit (loss) before tax | 149,942 | 567,350 | 581,310 |
| Income tax expense (benefits) | 40,000 | 157,732 | 137,346 |
| Net profit (loss) of ongoing business for the current period | 109,942 | 409,618 | 443,964 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | 109,942 | 409,618 | 443,964 |
| Other comprehensive profit (loss), net | 593,379 | 39,497 | -27,874 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | 703,321 | 449,115 | 416,090 |
| Net profit (loss) attributable to owners of parent company | 110,681 | 412,574 | 444,458 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | -739 | -2,956 | -494 |
| Comprehensive profit (loss) attributable to owners of parent company | 704,060 | 452,855 | 416,342 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | -739 | -3,740 | -252 |
| Basic earnings per share (yuan) | 1 | 4 | 4 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | 177,648 | 618,306 | 1,041,017 |
| Net cash inflows (outflows) from investing activities | -92,246 | -577,505 | -725,241 |
| Net cash inflow (outflow) from financing activities | 157,822 | -14,227 | -424,147 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 536 | 4,852 | -4,545 |
| Increase (decrease) in cash and cash equivalents in the current period | 243,760 | 31,426 | -112,916 |
| Beginning balance of cash and cash equivalents | 520,648 | 489,222 | 602,138 |
| Ending balance of cash and cash equivalents | 764,408 | 520,648 | 489,222 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Current asset | 3,262,147 | 2,917,179 | 3,377,906 |
| Non-current asset | 5,214,831 | 4,484,560 | 4,411,714 |
| Total asset | 8,476,978 | 7,401,739 | 7,789,620 |
| Current liability | 3,047,736 | 2,621,509 | 2,993,458 |
| Non-current liability | 361,586 | 216,483 | 350,365 |
| Total liability | 3,409,322 | 2,837,992 | 3,343,823 |
| share capital | 1,007,060 | 1,007,060 | 1,007,060 |
| Equity - secruity token | - | - | - |
| capital reserve | 420,027 | 418,027 | 564,657 |
| retained earning | 3,040,431 | 3,131,162 | 2,914,212 |
| Other equity | 555,890 | -37,489 | -71,982 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 5,023,408 | 4,518,760 | 4,413,947 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | 44,248 | 44,987 | 31,850 |
| Total Equity | 5,067,656 | 4,563,747 | 4,445,797 |
| Share capital awaiting retirement (unit: share) | - | - | - |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 49 | 44 | 43 |
| 標案名稱 | 機關名稱 | 決標日期 | 決標金額 | 是否得標 |
|---|---|---|---|---|
| Haux高壓氧氣治療艙維修案 | 臺中榮民總醫院 | 114/04/07 | 738000.0 | 是 |
| 單人式高壓氧氣治療艙 | 衛生福利部新營醫院 | 113/05/21 | 否 | |
| 113-115年度HAUX廠牌多人高壓氧艙保養維護 | 國防部軍醫局 | 113/05/16 | 642500.0 | 是 |
| 高壓氧操艙軟體更新(含電腦)1組 | 臺北榮民總醫院 | 112/11/22 | 2430000.0 | 是 |
| 單人高壓氧治療艙1台採購案 | 衛生福利部南投醫院 | 112/10/17 | 3650000.0 | 是 |
| 整形外科高壓氧多人治療艙之故障維修 | 高雄榮民總醫院 | 112/07/13 | 780000.0 | 是 |
| 高壓氧多人艙設備電腦模式升級1式 | 高雄榮民總醫院 | 112/06/29 | 2430000.0 | 是 |
| 單人式高壓氧治療艙採購案 | 衛生福利部恆春旅遊醫院 | 112/06/09 | 3650000.0 | 是 |
| 112-113年度HAUX廠牌多人高壓氧艙保養維護 | 國防部軍醫局 | 112/05/04 | 228000.0 | 是 |
| 胸腔部1台「HAUX高壓氧多人艙」設備故障修復勞務採購 | 臺北榮民總醫院 | 111/12/14 | 870000.0 | 是 |
| 貨櫃型減壓艙 | 國防部海軍司令部 | 111/06/28 | 否 | |
| 高壓氧氣艙，多人醫療用等3項 | 國防部 | 111/04/15 | 22700000.0 | 是 |
| 高壓氧單人艙等 5項儀器設備（詳招標品項表） | 臺中榮民總醫院 | 111/01/13 | 4275000.0 | 是 |
| 111年度醫療儀器設備集中採購 | 臺北榮民總醫院 | 110/12/08 | 170000.0 | 是 |
| 高壓氧艙-多人艙 | 國立成功大學醫學院附設醫院 | 109/09/29 | 27000000.0 | 是 |
| 高壓氧治療艙附設消防系統維修案 | 臺中榮民總醫院 | 109/08/18 | 240000.0 | 是 |
| 整形外科高壓氧多人治療艙之故障維修 | 高雄榮民總醫院 | 109/08/06 | 800000.0 | 是 |
| 高壓氧艙電腦操控系統 | 臺中榮民總醫院 | 109/07/08 | 1680000.0 | 是 |
